Skip to main content
Equibles

Invesco Ltd.

Position in NVCR — NovoCure Ltd

CIK 914208 Atlanta, GA
Back to NVCR Full portfolio

Position in NVCR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,232,583
+$1,854,520 QoQ
Shares Held
213,372
+68.8% QoQ
Ownership
0.183%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 217 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 99% None 1%

Common Shares in NVCR Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $8,155,863,696 across 75 Medical Devices names. NVCR ranks #35 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MDT
Medtronic plc
 17,885,150 $1,399,155,274
2 GEHC
GE HealthCare Technologies Inc.
 18,296,350 $1,171,149,358
3 DXCM
Dexcom Inc
 15,288,133 $1,029,655,749
4 ABT
Abbott Laboratories
 8,817,240 $800,076,351
5 BSX
Boston Scientific Corp
 13,800,748 $589,015,917
6 SYK
Stryker Corp
 1,855,162 $584,079,197
7 STE
STERIS plc
 1,806,187 $380,328,785
8 EW
Edwards Lifesciences Corp
 3,977,518 $359,806,272

All Filings in NVCR

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,232,583 213,372
2026-03-31 $1,378,063 126,428
2025-12-31 $878,824 67,968
2025-09-30 $978,998 75,774
2025-06-30 $1,606,929 90,277
2025-03-31 $1,809,565 101,547
2024-12-31 $5,646,323 189,474
2024-09-30 $1,715,797 109,776
2024-06-30 $1,882,448 109,892
2024-03-31 $2,205,954 141,136
2023-12-31 $1,569,440 105,120
2023-09-30 $2,996,032 185,513
2023-06-30 $6,435,693 155,077
2023-03-31 $9,126,360 151,752
2022-12-31 $11,018,708 150,221
2022-09-30 $6,240,539 82,134
2022-06-30 $5,994,721 86,255
2022-03-31 $5,826,672 70,328
2021-12-31 $4,530,475 60,342
2021-09-30 $17,135,304 147,502
2021-06-30 $54,289,113 244,744
2021-03-31 $16,511,263 124,915
2020-12-31 $11,373,918 65,730
2020-09-30 $1,819,917 16,350
2020-06-30 $1,611,714 27,179
2020-03-31 $46,508,841 690,657